Overall Survival After Allogeneic Transplantation in Advanced Cutaneous T-Cell Lymphomas (CUTALLO): A Propensity Score-Matched Controlled Prospective Study.
第一作者:
Adèle,de Masson
第一单位:
Department of Dermatology, Saint-Louis Hospital, AP-HP, Paris, France.;INSERM U1342 Institut de Recherche Saint-Louis, Paris, France.;Université Paris Cité, Paris, France.
作者:
Adèle,de Masson [1]
;
Marie,Beylot-Barry [2]
;
Caroline,Ram-Wolff [3]
;
Jean-Baptiste,Mear [4]
;
Stéphane,Dalle [5]
;
Jacques,Rouanet [6]
;
Saskia,Ingen-Housz-Oro [7]
;
Corentin,Orvain [8]
;
Julie,Abraham [9]
;
Olivier,Dereure [10]
;
Amandine,Charbonnier [11]
;
Jérôme,Cornillon [12]
;
Christine,Longvert [13]
;
Stéphane,Barete [14]
;
Serge,Boulinguez [15]
;
Ewa,Wierzbicka-Hainaut [16]
;
François,Aubin [17]
;
Marie-Thérèse,Rubio [18]
;
Marc,Bernard [4]
;
Aline,Schmidt-Tanguy [19]
;
Roch,Houot [20]
;
Anne,Pham-Ledard [2]
;
David,Michonneau [21]
;
Hélène,Labussière-Wallet [22]
;
Jean-David,Bouaziz [1]
;
Florent,Grange [23]
;
Hélène,Moins-Teisserenc [24]
;
Katayoun,Jondeau [25]
;
Samia,Mourah [26]
;
Maxime,Battistella [27]
;
Etienne,Daguindau [28]
;
Michael,Loschi [29]
;
Alexandra,Picard [30]
;
Nathalie,Franck [31]
;
Natacha,Maillard [32]
;
Anne,Huynh [33]
;
Stéphanie,Nguyen [34]
;
Ambroise,Marçais [35]
;
Guillaume,Chaby [36]
;
Patrice,Ceballos [37]
;
Yannick,Le Corre [38]
;
Sébastien,Maury [39]
;
Jacques-Olivier,Bay [40]
;
Henri,Adamski [41]
;
Emmanuel,Bachy [42]
;
Edouard,Forcade [43]
;
Gérard,Socié [44]
;
Martine,Bagot [1]
;
Sylvie,Chevret [45]
;
Régis,Peffault de Latour [46]
;
CUTALLO Investigators, Groupe Français d’Etude des Lymphomes Cutanés and Société Française de Greffe de Moëlle et Thérapie Cellulaire
作者单位:
Department of Dermatology, Saint-Louis Hospital, AP-HP, Paris, France.;INSERM U1342 Institut de Recherche Saint-Louis, Paris, France.;Université Paris Cité, Paris, France.
[1]
Department of Dermatology, CHU de Bordeaux, Bordeaux, France.;INSERM U1312, Bordeaux Institute of Oncology, Team 5, University of Bordeaux, Bordeaux, France.
[2]
Department of Dermatology, Saint-Louis Hospital, AP-HP, Paris, France.
[3]
Department of Hematology, L'Hôpital Pontchaillou, CHU de Rennes, Rennes, France.
[4]
Department of Dermatology, Hôpital Lyon-Sud, Lyon, France.
[5]
Department of Dermatology, CHU de Clermont-Ferrand, Clermont-Ferrand, France.
[6]
Department of Dermatology, AP-HP, Hôpital Henri Mondor, University Paris-Est Créteil, Créteil, France.
[7]
Department of Hematology, CHU d'Angers, Angers, France.;Fédération Hospitalo-Universitaire Grand-Ouest Acute Leukemia, FHU-GOAL, Angers, France.;INSERM UMR 1307, CNRS UMR 6075, Nantes Université, CRCI2NA, Université d'Angers, Angers, France.
[8]
Department of Hematology, CHU de Limoges, Limoges, France.
[9]
Department of Dermatology, University of Montpellier, Montpellier, France.;INSERM U1058 Pathogenesis and Control of Chronic and Emergent Infections, University of Montpellier, Montpellier, France.
[10]
Department of Hematology, CHU d'Amiens, Amiens, France.
[11]
Department of Clinical Hematology and Cellular Therapy, CHU de Saint-Etienne, Saint-Etienne, France.
[12]
Department of Dermatology, CHU Ambroise Paré, AP-HP, Boulogne-Billancourt, France.
[13]
Department of Dermatology, CHU Pitié-Salpêtrière, AP-HP, Paris, France.
[14]
Department of Dermatology, CHU de Toulouse, Toulouse, France.
[15]
Department of Dermatology, CHU de Poitiers, Poitiers, France.
[16]
Department of Dermatology, CHU de Besançon, Besançon, France.
[17]
Department of Hematology, Hôpital Brabois, CHRU Nancy, Nancy, France.;CNRS UMR 7365, IMoPA, Biopole, University of Lorraine, Nancy, France.
[18]
Department of Hematology, CHU d'Angers, Angers, France.
[19]
Department of Hematology, CHU de Rennes, Université de Rennes, INSERM, Rennes, France.
[20]
INSERM U1342 Institut de Recherche Saint-Louis, Paris, France.;Université Paris Cité, Paris, France.;Department of Hematology and Bone Marrow Transplantation, Saint-Louis Hospital, AP-HP, Paris, France.
[21]
Hospital Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France.
[22]
Department of Dermatology, Centre Hospitalier de Valence, Valence, France.
[23]
Université Paris Cité, Paris, France.;Hematology Laboratory, Saint-Louis Hospital, AP-HP, Paris, France.
[24]
Department of Hematology, CHU Ambroise Paré, AP-HP, Boulogne-Billancourt, France.
[25]
INSERM U1342 Institut de Recherche Saint-Louis, Paris, France.;Université Paris Cité, Paris, France.;Department of Tumor Genomics and Pharmacology, Saint-Louis Hospital, AP-HP, Paris, France.
[26]
INSERM U1342 Institut de Recherche Saint-Louis, Paris, France.;Université Paris Cité, Paris, France.;Pathology Laboratory, Saint-Louis Hospital, AP-HP, Paris, France.
[27]
Department of Hematology, CHU de Besançon, Besançon, France.
[28]
Department of Hematology, Hôpital L'Archet, Centre Hospitalier Universitaire de Nice, Nice, France.
[29]
Department of Dermatology, CHU de Nice, Nice, France.
[30]
Department of Dermatology, Hôpital Cochin, AP-HP, Paris, France.
[31]
Department of Hematology, CHU de Poitiers, Poitiers, France.
[32]
Department of Hematology, CHU Toulouse, IUCT Oncopole, Toulouse, France.
[33]
Department of Hematology, CHU Pitié-Salpêtrière, AP-HP, Paris, France.
[34]
Department of Hematology, CHU Necker, AP-HP, Paris, France.
[35]
Department of Dermatology, CHU d'Amiens, Amiens, France.
[36]
Department of Hematology, CHU de Montpellier, Montpellier, France.
[37]
Department of Dermatology, CHU d'Angers, Angers, France.
[38]
Department of Hematology, CHU Henri-Mondor, AP-HP, Créteil, France.
[39]
Department of Hematology, CHU de Clermont-Ferrand, Clermont-Ferrand, France.
[40]
Department of Dermatology, Hôpital Pontchaillou, CHU de Rennes, Rennes, France.
[41]
Department of Hematology, CHU de Lyon, Lyon, France.
[42]
Department of Clinical Hematology and Cellular Therapy, CHU Bordeaux, Bordeaux, France.
[43]
INSERM U1342 Institut de Recherche Saint-Louis, Paris, France.;Université Paris Cité, Paris, France.;CNRS UMR 7365, IMoPA, Biopole, University of Lorraine, Nancy, France.
[44]
Université Paris Cité, Paris, France.;Department of Biostatistics, Saint-Louis Hospital, AP-HP, Paris, France.;ECSTRRA Team, INSERM, Paris, France.
[45]
Université Paris Cité, Paris, France.;CNRS UMR 7365, IMoPA, Biopole, University of Lorraine, Nancy, France.
[46]
医学主题词
人类(Humans);女(雌)性(Female);淋巴瘤, T细胞, 皮肤(Lymphoma, T-Cell, Cutaneous);男(雄)性(Male);中年人(Middle Aged);造血干细胞移植(Hematopoietic Stem Cell Transplantation);前瞻性研究(Prospective Studies);皮肤肿瘤(Skin Neoplasms);成年人(Adult);倾向性评分(Propensity Score);老年人(Aged);移植, 同种(Transplantation, Homologous);存活率(Survival Rate)
DOI
10.1200/JCO-25-00183
PMID
40513043
发布时间
2025-07-30
- 浏览0
Journal of clinical oncology
Journal of clinical oncology
2461-2466页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文





换一批



